معرفی
Marc Froissart is a Full Professor at the University of Lausanne (UNIL) and Chief Physician at the Lausanne University Hospital (CHUV), where he serves as Director of the Clinical Research Center (CRC) within the Faculty of Biology and Medicine. His appointment as full professor and chief physician took effect on December 1, 2018. The CRC, under his leadership, supports academic clinical research through methodological, regulatory, and logistical services and has grown significantly in project volume and staffing.
- University: University of Lausanne (UNIL)
- School: Faculty of Biology and Medicine (FBM)
- Department: Department of Training and Research (DFR), CHUV
- Position: Full Professor and Chief Physician
- Leadership: Director, Clinical Research Center (CRC), 2017–2022
Marc Froissart completed his medical training through the Paris Hospitals Internship, earning certifications in epidemiology and biostatistics from the University of Paris 11 Sud. He specialized in nephrology (1992) and nuclear medicine (1993), and obtained his PhD in renal physiology from Pierre & Marie Curie University in 1999.
His research interests span a continuum from basic to clinical research, focusing on renal physiology, cellular and medical imaging, and translational applications. He initiated the cellular imaging platform at the Institut des Cordeliers and led nuclear medicine units at Broussais Hospital and Georges Pompidou European Hospital. A central achievement is the NephroTest cohort, a multicenter study monitoring chronic kidney disease in nearly 2,000 patients, for which he serves as principal investigator. His work bridges fundamental science with patient-oriented research, emphasizing methodological rigor and regulatory compliance in clinical trials.
Although no individual publications are listed in the provided text, his research output reflects a strong focus on nephrology, imaging technologies, cohort development, and clinical research infrastructure. His leadership in establishing national platforms—such as the SCTO’s Regulatory Affairs platform—demonstrates a commitment to improving the efficiency and visibility of academic clinical research in Switzerland.
Marc Froissart has held significant academic and industry roles, including Associate Professor of Physiology at both Pierre & Marie Curie University (1996–2000) and Paris Descartes University (2000–2010), Head of Research in Renal Epidemiology at Inserm 1018 (2005–2010), and Medical Director of Clinical Research at Amgen Europe (2011–2015). He served as Visiting Professor at FBM from 2015 to 2018 before his full appointment. He has secured institutional growth and funding for the CRC, expanding its team and project portfolio substantially. He has also contributed to national initiatives through the Swiss Clinical Trial Organisation (SCTO).
He leads the Clinical Research Center (CRC), a key component of CHUV’s Directorate of Innovation and Clinical Research, and a member of the SCTO network. The CRC provides comprehensive support for clinical investigations, including methodological design, regulatory submissions, data management, monitoring, nursing services, and investigator training. It also hosts the Research Consent Unit and is developing a national regulatory affairs platform under SCTO.
